Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1
Clinical trial NCT03007719 · TERMINATED
Trial details
- NCT number
- NCT03007719
- Sponsor
- Lawrence Fong
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2019-01-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.